We determined no significant difference in the prognosis based on tumor-infiltrating CD3+ T lymphocyte (TIL) expression, which excluded the effect of the entire tumor-infiltrating CD3+ T lymphocyte (TIL) background, and then investigated a subpopulation of TCF7+ T cells. This evidence concerns the gene TCF7 and neoplasm.